ETFs & MarketsBasicPharma M&A Outlook Shifts: Big Deals Eyed Amid Mercedes-Benz Valuation Questions
The landscape for pharmaceutical mergers and acquisitions is under scrutiny, with potential shifts that could impact healthcare sector ETFs. Concurrently, analysts are questioning the valuation drivers for major automotive players like Mercedes-Benz.
Published 1 hour ago
Read more →